Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Orgenesis Inc. (ORGS)
USD0.37
+0.21 (+132.50%)
US OTC Healthcare Biotechnology
Address
20271 Goldenrod Lane 20876
Germantown, MD, US
Germantown, MD, US
CEO
Vered Caplan
Website
orgenesis.com
IPO
2012-03-13
CIK 1460602 ISIN US68619K3032
Description
Orgenesis Inc. is a global biotechnology firm dedicated to the field of cell and gene therapies. The company has engineered an innovative Point of Care (POCare) platform. This system incorporates a portfolio of licensed POCare therapeutics, which are manufactured and prepared using automated, self-contained POCare technology within a cooperative network. Orgenesis primarily concentrates on autologous therapies, developing customized processes and systems for each treatment. These utilize a closed, automated processing methodology, validated for safe and compliant production directly at the patient's location, facilitating immediate therapeutic application. Established in 2008 as Business Outsourcing Service, Inc., the company adopted the name Orgenesis Inc. in August 2011 and is headquartered in Germantown, Maryland.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.37
+0.21 (+132.50%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
1.9K
Beta
2.97
Float Shares
3.45M
Free Float %
66.8%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +1,163.38% | +47.50% | +96.67% | +247.06% | +293.33% | -69.74% | -95.04% | -98.80% | -98.60% | -99.67% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (1 ratings, all time)
Buy
Price Targets & DCF
Current price
0.37
Ratings Trend (MoM)
100% Bullish
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-19.21
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
0 / 10
No MOAT
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%-98.5% Q3'24: +215.5% (vs Q3'23)
-
EPS growth Biotechnology: +29.7%-223.7% Q3'24: -144.2% (vs Q3'23)
-
FCF margin FCF growth · Biotechnology: +16.2%-5,338.1% Q3'24: -1,351.0% (vs Q3'23)
-
EBIT margin Biotechnology: +0.0%-11,750.6% Q3'24: -2,363.4% (vs Q3'23)
-
ROIC Biotechnology: -16.1%-7,775.0% Q3'24: +474.0% (vs Q3'23)
-
Share dilution Biotechnology: -3.4%+15.6% Q3'24: +61.7% (vs Q3'23)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.37× Q3'24: -0.56× (vs Q3'23)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
|---|---|---|---|---|---|---|---|---|
| Revenue |
10.09M
est: 10.21M (-1.2%)
|
18.66M
est: 20.63M (-9.6%)
|
33.26M
est: 33.50M (-0.7%)
|
7.65M
est: 51.70M (-85.2%)
|
35.50M
est: 37.60M (-5.6%)
|
36.03M
est: 30.70M (+17.3%)
|
530.0K
est: 50.30M (-98.9%)
|
70.30M
est.
|
| EBITDA |
-9.85M
est: -6.61M (-48.9%)
|
-12.39M
est: -13.36M (+7.3%)
|
-18.91M
est: -21.69M (+12.8%)
|
-94.21M
est: -33.48M (-181.4%)
|
-15.72M
est: -24.35M (+35.4%)
|
-8.16M
est: -19.88M (+59.0%)
|
-60.72M
est: -32.57M (-86.4%)
|
-45.52M
est.
|
| EBIT |
-12.44M
est: -7.06M (-76.1%)
|
-15.01M
est: -14.28M (-5.2%)
|
-22.32M
est: -23.18M (+3.7%)
|
-95.48M
est: -35.77M (-166.9%)
|
-17.58M
est: -26.02M (+32.4%)
|
-10.14M
est: -21.24M (+52.3%)
|
-62.28M
est: -34.80M (-78.9%)
|
-48.64M
est.
|
| Net Income |
-12.37M
est: -37.71M (+67.2%)
|
-18.29M
est: -265.42M (+93.1%)
|
-26.04M
est: -458.32M (+94.3%)
|
-95.81M
est: -188.55M (+49.2%)
|
-18.06M
est: -136.34M (+86.8%)
|
-14.89M
est: -107.33M (+86.1%)
|
-55.36M
est: 60.92M (-190.9%)
|
176.95M
est.
|
| SGA |
10.69M
est: 141.78M (-92.5%)
|
16.61M
est: 286.49M (-94.2%)
|
25.25M
est: 465.18M (-94.6%)
|
18.97M
est: 717.90M (-97.4%)
|
14.71M
est: 522.11M (-97.2%)
|
16.16M
est: 426.30M (-96.2%)
|
34.62M
est: 698.46M (-95.0%)
|
976.18M
est.
|
| EPS |
-1.28
est: -1.30 (+1.5%)
|
-1.37
est: -9.15 (+85.0%)
|
-1.64
est: -15.80 (+89.6%)
|
-4.46
est: -6.50 (+31.4%)
|
-0.74
est: -4.70 (+84.3%)
|
-0.59
est: -3.70 (+84.1%)
|
-1.91
est: 2.10 (-191.0%)
|
6.10
est.
|
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-33.58M
OE per share TTM
-6.26
Owner's Yield
-120.71%
Maintenance CapEx ratio
1.08%
Maint CapEx / Avg PPE
66.2%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
12
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NEW DIMENSIONS TRADING LTD. | 1.37M | 5.36% | — | — | 1.37M | — | OO | CAYMAN ISLANDS | 2022-11-21 | ↗ |
| 2 | Bergen Asset Management, LLC | 1.35M | 5.60% | — | 1.35M | — | — | OO | Delaware | 2020-10-22 | ↗ |
| 3 | Bergen Special Opportunity Fund, LP | 1.35M | 5.60% | — | 1.35M | — | — | PN | Delaware | 2020-10-22 | ↗ |
| 4 | Eugene Tablis | 1.35M | 5.60% | — | 1.35M | — | — | IN | Delaware | 2020-10-22 | ↗ |
| 5 | Long Hill Capital V, LLC | 1.35M | 5.60% | — | 1.35M | — | — | PN | Delaware | 2020-10-22 | ↗ |
| 6 | The Phoenix Holdings Ltd. | 1.14M | 7.06% | — | 1.14M | — | 1.14M | CO | Israel | 2020-01-29 | ↗ |
| 7 | Sphera Funds Management Ltd. | 525.2K | 2.13% | — | 525.2K | — | 525.2K | CO | Israel | 2021-02-16 | ↗ |
| 8 | Sphera Global Healthcare GP Ltd. | 525.2K | 2.13% | — | 525.2K | — | 525.2K | CO | Israel | 2021-02-16 | ↗ |
| 9 | Sphera Global Healthcare Management LP | 525.2K | 2.13% | — | 525.2K | — | 525.2K | CO | Israel | 2021-02-16 | ↗ |
| 10 | 2. | 10.00 | 6.00% | — | — | — | — | OO | Delaware | 2023-01-19 | ↗ |
| 11 | Moshe Arkin | 10.00 | 0.00% | — | — | — | — | IN | Israel | 2021-02-16 | ↗ |
| 12 | Identification Nos. of above persons (. | — | 0.00% | — | — | — | 10.00 | OO | Belgium | 2018-01-25 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
4
Sells
0
Shares acquired
469.9K
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+469,890
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-05 | MALIK ARIEL | 10% Owner | — | — | Common Stock | 0 | 0.00 | — | 1,200,000 | I | ↗ |
| 2024-12-12 | Vider Itzhak | Director | A-Award | A | Stock Option | 1,500 | 0.98 | 1.5K | 1,500 | D | ↗ |
| 2024-12-12 | PELAVIN ADAM | Director | A-Award | A | Stock Option | 1,250 | 0.98 | 1.2K | 1,250 | D | ↗ |
| 2024-12-12 | Nanda Ashish | Director | A-Award | A | Stock Option | 1,835 | 0.98 | 1.8K | 1,835 | D | ↗ |
| 2024-12-12 | NAGARAJ SANTHOSH | Director | A-Award | A | Stock Option | 1,250 | 0.98 | 1.2K | 1,250 | D | ↗ |
| 2024-12-12 | BHALAJI JAGANNATHAN | Director | A-Award | A | Stock Option | 1,250 | 0.98 | 1.2K | 1,250 | D | ↗ |
| 2024-12-12 | Adler Yaron | Director | A-Award | A | Stock Option | 1,750 | 0.98 | 1.7K | 1,750 | D | ↗ |
| 2024-11-04 | Safier Jacob | 10% Owner | A-Award | A | Warrant (right to buy) | 242,718 | 1.03 | 250.0K | 242,718 | D | ↗ |
| 2024-10-28 | PELAVIN ADAM | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-10-28 | NAGARAJ SANTHOSH | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-10-28 | BHALAJI JAGANNATHAN | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-08-21 | Safier Jacob | 10% Owner | A-Award | A | Warrant (right to buy) | 970,873 | 1.03 | 1,000.0K | 970,873 | D | ↗ |
| 2024-07-23 | Nanda Ashish | Director | A-Award | A | Stock Option (Right to Buy) | 189,320 | 0.64 | 121.2K | 189,320 | — | ↗ |
| 2024-07-23 | Caplan Vered | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 85,000 | 0.64 | 54.4K | 85,000 | — | ↗ |
| 2024-07-08 | Vider Itzhak | Director | A-Award | A | Stock Option (Right to Buy) | 6,250 | 0.65 | 4.1K | 6,250 | — | ↗ |
| 2024-06-27 | Miller Victor | Officer | A-Award | A | Stock Option (Right to Buy) | 200,000 | 0.63 | 126.0K | 200,000 | — | ↗ |
| 2024-06-27 | Goodman Mark | Director | A-Award | A | Stock Option (Right to Buy) | 6,250 | 0.63 | 3.9K | 6,250 | — | ↗ |
| 2024-06-24 | Safier Jacob | 10% Owner | S-Sale | D | Common Stock | 10,000 | 0.58 | 5.8K | 3,110,100 | I | ↗ |
| 2024-04-16 | Safier Jacob | 10% Owner | S-Sale | D | Common Stock | 10,000 | 0.50 | 5.0K | 3,110,100 | I | ↗ |
| 2024-04-10 | Safier Jacob | 10% Owner | S-Sale | D | Common Stock | 10,000 | 0.54 | 5.4K | 3,110,100 | I | ↗ |
| 2024-04-01 | Miller Victor | Officer | M-Exempt | D | Stock Option (Right to Buy) | 25,000 | 0.50 | 12.5K | 175,000 | — | ↗ |
| 2024-02-01 | Safier Jacob | 10% Owner | P-Purchase | A | Common Stock (par value $0.01) | 10,100 | 0.33 | 3.3K | 3,110,100 | — | ↗ |
| 2024-01-31 | Safier Jacob | 10% Owner | P-Purchase | A | Common Stock (par value $0.01) | 5,000 | 0.35 | 1.7K | 3,100,000 | — | ↗ |
| 2024-01-30 | Safier Jacob | 10% Owner | P-Purchase | A | Common Stock (par value $0.01) | 25,000 | 0.33 | 8.2K | 3,095,000 | — | ↗ |
| 2024-01-26 | Safier Jacob | 10% Owner | P-Purchase | A | Common Stock (par value $0.01) | 25,000 | 0.32 | 8.0K | 3,070,000 | — | ↗ |
| 2024-01-25 | Safier Jacob | 10% Owner | P-Purchase | A | Common Stock (par value $0.01) | 25,000 | 0.32 | 7.9K | 3,045,000 | — | ↗ |
| 2024-01-22 | Safier Jacob | 10% Owner | P-Purchase | A | Common Stock (par value $0.01) | 10,000 | 0.29 | 2.9K | 3,020,000 | — | ↗ |
| 2024-01-18 | Safier Jacob | 10% Owner | P-Purchase | A | Common Stock (par value $0.01) | 10,000 | 0.33 | 3.3K | 3,010,000 | — | ↗ |
| 2024-01-11 | Safier Jacob | 10% Owner | P-Purchase | A | Common Stock (par value $0.01) | 2,000 | 0.33 | 659.40 | 3,000,000 | — | ↗ |
| 2024-01-10 | Safier Jacob | 10% Owner | P-Purchase | A | Common Stock (par value $0.01) | 10,000 | 0.37 | 3.7K | 2,998,000 | — | ↗ |
| 2024-01-02 | Miller Victor | Officer | A-Award | A | Stock Option (Right to Buy) | 200,000 | 0.50 | 100.0K | 200,000 | — | ↗ |
| 2023-12-21 | Safier Jacob | 10% Owner | P-Purchase | A | Common Stock (par value $0.01) | 10,000 | 0.45 | 4.5K | 2,988,000 | — | ↗ |
| 2023-12-20 | Yachin Guy | Director | A-Award | A | Stock Option | 19,600 | 0.45 | 8.8K | 19,600 | — | ↗ |
| 2023-12-20 | SIDRANSKY DAVID | Director | A-Award | A | Stock Option | 20,450 | 0.45 | 9.2K | 20,450 | — | ↗ |
| 2023-12-20 | Philips Mario | Director | A-Award | A | Stock Option | 13,750 | 0.45 | 6.2K | 13,750 | — | ↗ |
| 2023-12-20 | Nanda Ashish | Director | A-Award | A | Stock Option | 15,850 | 0.45 | 7.1K | 15,850 | — | ↗ |
| 2023-12-20 | Adler Yaron | Director | A-Award | A | Stock Option | 15,000 | 0.45 | 6.8K | 15,000 | — | ↗ |
| 2023-12-12 | Safier Jacob | 10% Owner | P-Purchase | A | Common Stock (par value $0.01) | 3,000 | 0.54 | 1.6K | 2,978,000 | — | ↗ |
| 2023-12-11 | Safier Jacob | 10% Owner | P-Purchase | A | Common Stock (par value $0.01) | 2,000 | 0.53 | 1.1K | 2,975,000 | — | ↗ |
| 2023-12-01 | Safier Jacob | 10% Owner | P-Purchase | A | Common Stock (par value $0.01) | 1,016 | 0.46 | 466.85 | 2,973,000 | — | ↗ |
| 2023-11-24 | Safier Jacob | 10% Owner | P-Purchase | A | Common Stock (par value $0.01) | 5,000 | 0.54 | 2.7K | 2,971,984 | — | ↗ |
| 2023-11-21 | Safier Jacob | 10% Owner | P-Purchase | A | Common Stock (par value $0.01) | 5,800 | 0.51 | 3.0K | 2,966,984 | — | ↗ |
| 2023-11-10 | Safier Jacob | 10% Owner | P-Purchase | A | Common Stock (par value $0.01) | 1,184 | 0.58 | 687.67 | 2,961,184 | — | ↗ |
| 2023-11-09 | Safier Jacob | 10% Owner | P-Purchase | A | Common Stock (par value $0.01) | 20,000 | 0.65 | 13.1K | 2,960,000 | — | ↗ |
| 2023-11-08 | Safier Jacob | 10% Owner | P-Purchase | A | Common Stock (par value $0.01) | 20,000 | 0.71 | 14.2K | 2,940,000 | — | ↗ |
| 2023-11-02 | Safier Jacob | 10% Owner | P-Purchase | A | Common Stock (par value $0.01) | 20,000 | 0.84 | 16.9K | 2,920,000 | — | ↗ |
| 2023-11-01 | Safier Jacob | 10% Owner | P-Purchase | A | Common Stock (par value $0.01) | 3,437 | 0.81 | 2.8K | 2,900,000 | — | ↗ |
| 2023-10-31 | Safier Jacob | 10% Owner | P-Purchase | A | Common Stock (par value $0.01) | 5,000 | 0.74 | 3.7K | 2,896,563 | — | ↗ |
| 2023-10-27 | Safier Jacob | 10% Owner | P-Purchase | A | Common Stock (par value $0.01) | 500 | 0.93 | 465.25 | 2,891,563 | — | ↗ |
| 2023-10-25 | Safier Jacob | 10% Owner | P-Purchase | A | Common Stock (par value $0.01) | 500 | 0.88 | 437.60 | 2,891,063 | — | ↗ |
| 2023-10-24 | Safier Jacob | 10% Owner | P-Purchase | A | Common Stock (par value $0.01) | 10,000 | 0.90 | 9.0K | 2,890,563 | — | ↗ |
| 2023-10-10 | Safier Jacob | 10% Owner | P-Purchase | A | Common Stock (par value $0.01) | 603 | 0.86 | 519.06 | 2,880,563 | — | ↗ |
| 2023-10-06 | Safier Jacob | 10% Owner | P-Purchase | A | Common Stock (par value $0.01) | 5,100 | 0.93 | 4.7K | 2,879,960 | — | ↗ |
| 2023-10-05 | Safier Jacob | 10% Owner | P-Purchase | A | Common Stock (par value $0.01) | 10,000 | 0.80 | 8.0K | 2,874,860 | — | ↗ |
| 2023-09-28 | Safier Jacob | 10% Owner | P-Purchase | A | Common Stock (par value $0.01) | 25,000 | 0.67 | 16.8K | 2,864,860 | — | ↗ |
| 2023-09-21 | Safier Jacob | 10% Owner | P-Purchase | A | Common Stock (par value $0.01) | 100,000 | 0.69 | 69.0K | 2,839,860 | — | ↗ |
| 2023-09-07 | Safier Jacob | 10% Owner | P-Purchase | A | Common Stock (par value $0.01) | 5,000 | 0.67 | 3.3K | 2,739,860 | — | ↗ |
| 2023-09-04 | Maltz Elliot | Officer | A-Award | A | Stock Option (Right to Buy) | 200,000 | 0.58 | 116.0K | 200,000 | — | ↗ |
| 2023-09-01 | Maltz Elliot | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-08-31 | Safier Jacob | 10% Owner | — | I | Common Stock (par value $0.01) | 0 | 0.00 | — | 2,734,860 | — | ↗ |
| 2022-12-23 | Yachin Guy | Director | A-Award | A | Stock Option | 19,600 | 0.00 | — | 19,600 | — | ↗ |
| 2022-12-23 | SIDRANSKY DAVID | Director | A-Award | A | Stock Option | 20,450 | 0.00 | — | 20,450 | — | ↗ |
| 2022-12-23 | Philips Mario | Director | A-Award | A | Stock Option | 13,750 | 0.00 | — | 13,750 | — | ↗ |
| 2022-12-23 | Nanda Ashish | Director | A-Award | A | Stock Option | 15,850 | 0.00 | — | 15,850 | — | ↗ |
| 2022-12-23 | Adler Yaron | Director | A-Award | A | Stock Option | 15,000 | 0.00 | — | 15,000 | — | ↗ |
| 2022-06-14 | Reithinger Neil | Officer | A-Award | A | Stock Option | 15,000 | 0.00 | — | 15,000 | — | ↗ |
| 2022-06-14 | Caplan Vered | Director / Officer | A-Award | A | Stock Option | 85,000 | 2.00 | 170.0K | 85,000 | — | ↗ |
| 2022-06-14 | Assa Kunik Efrat | Officer | A-Award | A | Stock Option | 15,000 | 0.00 | — | 15,000 | — | ↗ |
| 2022-01-28 | Caplan Vered | Director / Officer | M-Exempt | D | Stock Option (Right to Buy) | 278,191 | 0.01 | 3.3K | 0 | — | ↗ |
| 2021-12-16 | Yachin Guy | Director | A-Award | A | Stock Option (Right to Buy) | 19,600 | 2.89 | 56.6K | 19,600 | — | ↗ |
| 2021-12-16 | SIDRANSKY DAVID | Director | A-Award | A | Stock Option (Right to Buy) | 2,045 | 2.89 | 5.9K | 20,450 | — | ↗ |
| 2021-12-16 | Philips Mario | Director | A-Award | A | Stock Option (Right to Buy) | 13,750 | 2.89 | 39.7K | 13,750 | — | ↗ |
| 2021-12-16 | Nanda Ashish | Director | A-Award | A | Stock Option (Right to Buy) | 15,850 | 2.89 | 45.8K | 15,850 | — | ↗ |
| 2021-12-16 | Adler Yaron | Director | A-Award | A | Stock Option (Right to Buy) | 15,000 | 2.89 | 43.4K | 15,000 | — | ↗ |
| 2021-12-15 | Kunik Efrat Assa | Officer | — | D | Stock Option | 15,000 | 2.99 | 44.9K | 0 | — | ↗ |
| 2020-05-20 | SIDRANSKY DAVID | Director | P-Purchase | A | Common Stock | 10 | 6.98 | 69.80 | 180 | — | ↗ |
| 2020-05-13 | SIDRANSKY DAVID | Director | P-Purchase | A | Common Stock | 70 | 5.96 | 417.20 | 170 | — | ↗ |
| 2020-05-12 | SIDRANSKY DAVID | Director | P-Purchase | A | Common Stock | 90 | 5.90 | 531.00 | 100 | — | ↗ |
| 2020-05-07 | SIDRANSKY DAVID | Director | P-Purchase | A | Common Stock | 10 | 5.42 | 54.20 | 10 | — | ↗ |
| 2020-03-19 | Yachin Guy | Director | A-Award | A | Stock Option | 12,500 | 2.99 | 37.4K | 12,500 | — | ↗ |
| 2020-03-19 | SIDRANSKY DAVID | Director | A-Award | A | Stock Option | 12,500 | 2.99 | 37.4K | 12,500 | — | ↗ |
| 2020-03-19 | Reithinger Neil | Officer | A-Award | A | Stock Option | 15,000 | 2.99 | 44.9K | 15,000 | — | ↗ |
| 2020-03-19 | Philips Mario | Director | A-Award | A | Stock Option | 12,500 | 2.99 | 37.4K | 12,500 | — | ↗ |
| 2020-03-19 | Nanda Ashish | Director | A-Award | A | Stock Option | 12,500 | 2.99 | 37.4K | 12,500 | — | ↗ |
| 2020-03-19 | Ferber Sarah | Officer | A-Award | A | Stock Option | 3,750 | 2.99 | 11.2K | 3,750 | — | ↗ |
| 2020-03-19 | Caplan Vered | Director / Officer | A-Award | A | Stock Option | 85,000 | 2.99 | 254.2K | 85,000 | — | ↗ |
| 2020-03-19 | Adler Yaron | Director | A-Award | A | Stock Option | 12,500 | 2.99 | 37.4K | 12,500 | — | ↗ |
| 2020-01-09 | Philips Mario | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-12-17 | Yachin Guy | Director | A-Award | A | Stock Option | 12,500 | 2.99 | 37.4K | 12,500 | — | ↗ |
| 2019-12-17 | SIDRANSKY DAVID | Director | A-Award | A | Stock Option | 12,500 | 2.99 | 37.4K | 12,500 | — | ↗ |
| 2019-12-17 | Nanda Ashish | Director | A-Award | A | Stock Option | 12,500 | 2.99 | 37.4K | 12,500 | — | ↗ |
| 2019-12-17 | Adler Yaron | Director | A-Award | A | Stock Option | 12,500 | 2.99 | 37.4K | 12,500 | — | ↗ |
| 2018-10-22 | Yachin Guy | Director | A-Award | A | Stock Option | 28,750 | 5.99 | 172.2K | 28,750 | — | ↗ |
| 2018-10-22 | SIDRANSKY DAVID | Director | A-Award | A | Stock Option | 29,200 | 5.99 | 174.9K | 29,200 | — | ↗ |
| 2018-10-22 | Nanda Ashish | Director | A-Award | A | Stock Option | 27,100 | 5.99 | 162.3K | 27,100 | — | ↗ |
| 2018-10-22 | Ferber Sarah | Officer | A-Award | A | Stock Option | 3,750 | 5.99 | 22.5K | 3,750 | — | ↗ |
| 2018-10-22 | Caplan Vered | Director / Officer | A-Award | A | Stock Option | 85,000 | 5.99 | 509.2K | 85,000 | — | ↗ |
| 2018-10-22 | Adler Yaron | Director | A-Award | A | Stock Option | 28,750 | 5.99 | 172.2K | 28,750 | — | ↗ |
| 2018-06-28 | Caplan Vered | Officer | A-Award | A | Stock Option (Right to Buy Common Stock) | 250,000 | 8.36 | 2.09M | 250,000 | — | ↗ |
| 2018-06-11 | Adler Yaron | Director | C-Conversion | A | Common Stock | 37,662 | 0.00 | — | 37,662 | — | ↗ |
| 2018-05-14 | Bedoret Denis | Officer | A-Award | A | Stock Option | 15,000 | 8.43 | 126.5K | 15,000 | — | ↗ |
| 2017-11-17 | Universite Libre de Bruxelles | — | S-Sale | D | Common Stock | 204,396 | 1.83 | 373.6K | 408,792 | — | ↗ |
| 2017-11-17 | Bultot Hugues | Director | X-InTheMoney | A | Common Shares | 2,452,751 | 356,549.04 | 874.53B | 7,127,090 | — | ↗ |
| 2017-11-15 | Universite Libre de Bruxelles | — | S-Sale | D | Common Stock | 204,396 | 1.83 | 373.6K | 613,188 | — | ↗ |
| 2017-11-13 | Universite Libre de Bruxelles | — | S-Sale | D | Common Stock | 204,396 | 1.83 | 373.6K | 817,584 | — | ↗ |
| 2017-10-11 | Theodorus SCA | — | S-Sale | D | Common Stock | 2,500,000 | 0.25 | 625.0K | 2,952,358 | — | ↗ |
| 2017-10-11 | Theodorus II SA | — | S-Sale | D | Common Stock | 2,500,000 | 0.25 | 625.0K | 2,952,358 | — | ↗ |
| 2017-10-11 | Belenger Olivier | — | S-Sale | D | Common Stock | 5,000,000 | 0.25 | 1.25M | 5,904,716 | — | ↗ |
| 2017-09-21 | Belenger Olivier | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 10,904,716 | — | ↗ |
| 2017-09-11 | Theodorus SCA | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 5,452,358 | — | ↗ |
| 2017-09-11 | Theodorus II SA | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 5,452,358 | — | ↗ |
| 2017-07-11 | Bedoret Denis | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2017-06-07 | Caplan Vered | Director / Officer | A-Award | A | Stock Option (Right to Buy Common Stock) | 1,000,000 | 0.60 | 600.0K | 1,000,000 | — | ↗ |
| 2017-02-22 | Nanda Ashish | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2017-01-16 | Bultot Hugues | Director | J-Other | D | Common Shares | 376,115 | 0.00 | — | 4,674,339 | — | ↗ |
| 2016-12-09 | Yachin Guy | Director | A-Award | A | Stock Option | 41,667 | 4.80 | 200.0K | 41,667 | — | ↗ |
| 2016-12-09 | SIDRANSKY DAVID | Director | A-Award | A | Stock Option | 41,667 | 4.80 | 200.0K | 41,667 | — | ↗ |
| 2016-12-09 | Reithinger Neil | Officer | A-Award | A | Stock Option | 83,334 | 4.80 | 400.0K | 83,334 | — | ↗ |
| 2016-12-09 | Caplan Vered | Director / Officer | A-Award | A | Stock Option | 166,667 | 4.80 | 800.0K | 166,667 | — | ↗ |
| 2016-12-09 | Bultot Hugues | Director | A-Award | A | Stock Options | 500,000 | 0.40 | 200.0K | 750,000 | — | ↗ |
| 2016-12-09 | Adler Yaron | Director | A-Award | A | Stock Option | 41,667 | 4.80 | 200.0K | 41,667 | — | ↗ |
| 2016-04-27 | Caplan Vered | Director | A-Award | A | Stock Option (Right to Buy Common Stock) | 1,104,950 | 0.00 | 1.1K | 4,443,235 | — | ↗ |
| 2015-11-30 | Adler Yaron | Director | A-Award | A | Warrants | 9,616 | 6.24 | 60.0K | 9,616 | — | ↗ |
| 2015-08-07 | Shvartz Oded | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 21,967,890 | — | ↗ |
| 2015-06-18 | Bultot Hugues | Director | A-Award | A | Stock Options | 250,000 | 0.53 | 132.5K | 250,000 | — | ↗ |
| 2015-03-02 | Universite Libre de Bruxelles | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 1,021,980 | — | ↗ |
| 2015-03-02 | Theodorus SCA | 10% Owner | — | D | Option To Purchase | 2,452,751 | 0.00 | — | 0 | — | ↗ |
| 2015-03-02 | Theodorus II SA | 10% Owner | — | I | Option To Purchase | 2,452,751 | 0.00 | — | 0 | — | ↗ |
| 2015-03-02 | Buyse Chris Georges Frans | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2015-03-02 | Bultot Hugues | Director | — | D | Stock Options | 2,650,108 | 0.00 | — | 0 | — | ↗ |
| 2015-03-02 | Belenger Olivier | 10% Owner | — | I | Option To Purchase | 4,905,502 | 0.00 | — | 0 | — | ↗ |
| 2014-09-15 | Adler Yaron | Director | P-Purchase | A | 6% Convertible Note | 100,000 | 4.80 | 480.0K | 100,000 | — | ↗ |
| 2014-08-22 | Caplan Vered | Director / Officer | A-Award | A | Stock Option | 34,526 | 0.00 | 3.45 | 34,526 | — | ↗ |
| 2014-08-01 | Reithinger Neil | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2014-04-16 | Tenne Joseph | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2014-03-04 | Adler Yaron | Director | A-Award | A | Warrants | 16,026 | 6.24 | 100.0K | 16,026 | — | ↗ |
| 2013-07-17 | SIDRANSKY DAVID | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2013-07-16 | SIDRANSKY DAVID | Director | A-Award | A | Stock Option | 20,834 | 9.00 | 187.5K | 20,834 | — | ↗ |
| 2012-12-17 | DiPasquale Sav | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2012-08-07 | HANOCHI ETTI | Director | A-Award | A | Stock Options | 235,630 | 0.79 | 186.1K | 235,630 | — | ↗ |
| 2012-07-10 | Caplan Vered | Director | A-Award | A | Stock Options | 3,338,285 | 0.00 | 3.3K | 3,338,285 | — | ↗ |
| 2012-07-08 | Adler Yaron | Director | A-Award | A | Stock Options | 706,890 | 0.79 | 558.4K | 706,890 | — | ↗ |
| 2012-06-04 | Yachin Guy | Director | A-Award | A | Stock Option | 39,267 | 10.20 | 400.5K | 39,267 | — | ↗ |
| 2012-04-17 | Adler Yaron | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2012-04-06 | HANOCHI ETTI | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2012-04-02 | Yachin Guy | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2012-02-02 | Weinberg Dov | Officer | — | D | Stock Options | 706,904 | 0.69 | 487.8K | 0 | — | ↗ |
| 2012-02-02 | Ferber Sarah | Officer | — | D | stock options | 2,781,905 | 0.00 | 2.8K | 0 | — | ↗ |
| 2012-02-02 | Caplan Vered | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2012-02-02 | Benairie Jacob | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2012-02-02 | BenArie Jacob | Officer | — | D | Stock Options | 2,781,905 | 0.69 | 1.92M | 0 | — | ↗ |
| 2011-06-28 | Golez Jerome Peralta | Director / Officer / 10% Owner | S-Sale | D | common stock | 153,871 | 0.01 | 1.9K | 645,129 | — | ↗ |
| 2011-04-07 | Golez Jerome Peralta | Director / Officer / 10% Owner | — | D | common stock | 0 | 0.00 | — | 800,000 | — | ↗ |
| 2011-04-07 | Cuison Gilbert Adrias | Director / Officer / 10% Owner | — | D | common stock | 0 | 0.00 | — | 800,000 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-4.3K
Shares Outstanding
5.17M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2023 | Vered Caplan CEO | 259.0K | — | — | — | — | 82.4K | 341.4K | 0.00% | ↗ |
| 2 | 2023 | Elliot Maltz Former CFO, Treasurer & Secretary | 111.7K | — | — | 81.9K | — | — | 195.6K | 41.87% | ↗ |
| 3 | 2023 | Efrat Assa Kunik, Former Chief Development Officer | 129.6K | — | — | — | — | 18.7K | 148.3K | 0.00% | ↗ |
| 4 | 2022 | Vered Caplan CEO | 243.9K | — | — | 107.9K | — | 92.1K | 443.9K | 24.32% | ↗ |
| 5 | 2022 | Efrat Assa Kunik, Former Chief Development Officer | 162.3K | — | — | 19.0K | — | 44.5K | 225.8K | 8.43% | ↗ |
| 6 | 2022 | Efrat Assa Kunik, Chief Development Officer | 162.3K | — | — | 19.0K | — | 44.5K | 225.8K | 8.43% | ↗ |
| 7 | 2022 | Neil Reithinger CFO, Treasurer & Secretary | 126.0K | — | — | 19.0K | — | — | 145.1K | 13.13% | ↗ |
| 8 | 2021 | Vered Caplan CEO | 264.5K | 3.60M | — | — | — | 112.3K | 3.98M | 0.00% | ↗ |
| 9 | 2021 | Neil Reithinger CFO, Treasurer & Secretary | 239.7K | — | — | — | — | — | 239.7K | 0.00% | ↗ |
| 10 | 2021 | Efrat Assa-Kunik, Chief Development Officer | 169.5K | — | — | — | — | 46.4K | 215.9K | 0.00% | ↗ |
| 11 | 2021 | Efrat Assa Kunik, Chief Development Officer | 169.5K | — | — | — | — | 46.4K | 215.9K | 0.00% | ↗ |
| 12 | 2020 | Neil Reithinger CFO, Treasurer & Secretary | 255.2K | 200.0K | — | 30.2K | — | — | 485.5K | 6.23% | ↗ |
| 13 | 2020 | Vered Caplan CEO | 250.0K | 400.0K | — | 171.3K | — | 215.6K | 103.7K | 165.24% | ↗ |
| 14 | 2019 | Vered Caplan CEO | 250.0K | 200.0K | — | 871.0K | — | 77.0K | 1.40M | 62.30% | ↗ |
| 15 | 2019 | Darren Head, CEO of Masthercell Global | 250.0K | 112.5K | — | 9.2K | — | 120.0K | 491.7K | 1.88% | ↗ |
| 16 | 2019 | Denis Bedoret, President of MaSTherCell Global | 222.0K | 33.2K | — | 66.2K | — | — | 321.4K | 20.59% | ↗ |
| 17 | 2019 | Neil Reithinger CFO, Treasurer & Secretary | 213.7K | — | — | 23.0K | — | — | 236.6K | 9.71% | ↗ |
| 18 | 2018 | Vered Caplan CEO | 226.1K | 350.0K | — | 1.32M | — | 80.7K | 1.98M | 66.75% | ↗ |
| 19 | 2018 | Neil Reithinger CFO, Treasurer & Secretary | 266.5K | — | — | 139.6K | — | — | 406.0K | 34.38% | ↗ |
| 20 | 2018 | Denis Bedoret, President of MaSTherCell Global | 211.8K | 56.5K | — | 20.2K | — | — | 288.6K | 7.00% | ↗ |
| 21 | 2018 | Denis Bedoret, Managing Director of MaSTherCell | 112.7K | 56.5K | — | 20.2K | — | 43.3K | 288.6K | 7.00% | ↗ |
| 22 | 2018 | Sarah Ferber Chief Scientific Officer | 266.5K | — | — | 464.00 | — | 42.8K | 268.8K | 0.17% | ↗ |
| 23 | 2017 | Vered Caplan Chief Executive Officer & President | 156.2K | 150.0K | — | 685.3K | — | 63.3K | 1.05M | 64.97% | ↗ |
| 24 | 2017 | Vered Caplan CEO | — | 150.0K | — | 685.3K | — | 63.3K | 1.05M | 64.97% | ↗ |
| 25 | 2017 | Neil Reithinger CFO, Treasurer & Secretary | — | — | — | 136.1K | — | — | 248.8K | 54.72% | ↗ |
| 26 | 2017 | Neil Reithinger Chief Financial Officer, Treasurer & Secretary | 150.1K | — | — | 136.1K | — | — | 248.8K | 54.72% | ↗ |
| 27 | 2017 | Denis Bedoret, Managing Director of MaSTherCell | — | 31.3K | — | — | — | — | 239.8K | 0.00% | ↗ |
| 28 | 2016 | Vered Caplan Chief Executive Officer & President | — | — | — | 500.6K | — | 50.3K | 701.0K | 71.42% | ↗ |
| 29 | 2016 | Scott Carmer, Former CEO of Orgenesis Maryland Inc. | 112.4K | — | — | 313.5K | — | — | 555.2K | 56.47% | ↗ |
| 30 | 2016 | Vered Caplan CEO & President | 150.1K | — | — | 308.4K | — | 50.3K | 508.7K | 60.61% | ↗ |
| 31 | 2016 | Hugues Bultot President of MaSTherCell Subsidiary | 204.4K | — | — | — | — | 39.8K | 168.0K | 0.00% | ↗ |
| 32 | 2016 | Sarah Ferber Chief Scientific Officer | 108.6K | — | — | — | — | 39.8K | 152.2K | 0.00% | ↗ |
| 33 | 2016 | Neil Reithinger CFO, Treasurer & Secretary | 154.8K | — | — | — | — | — | 108.6K | 0.00% | ↗ |
| 34 | 2015 | Vered Caplan CEO & President | — | — | — | — | — | 52.1K | 202.0K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Vered Caplan | Chairperson of the Board, Chief Executive Officer & President | 324.2K | female |
| Sarah Ferber | Founder & Chief Scientific Officer | 268.3K | — |
| Doug Karriker | Chief Financial Officer, Secretary & Treasurer | 126.0K | male |
| Shimon Hassin | Chief Technology Officer | — | — |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ORGS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
